Taryn Cardenas

428P Key landmarks of male advanced breast cancer: Results of the GEICAM/2016-04 study

N. Martínez, María Purificación Martínez del Prado, C. Hernando Melia, S. Recalde Penabad et autres

es (code pays fourni par la source)

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

Noelia Martínez-Jáñez, Meritxell Bellet, L.M. Manso Sànchez, Fernando Henao et autres

PURPOSE: To evaluate the efficacy and safety of first-line therapy with palbociclib in a Spanish cohort treated after palbociclib approval. METHODS: /HER2- BC diagnosed between November 2017 and November 2019. The primary endpoint was real-world progression-free survival (rw-PFS). Secondary endpoints included overall …

es (code pays fourni par la source)

279P Early changes in bone turnover biomarkers during AI therapy are related to loss bone mineral density, data of the B-ABLE cohort

Taryn Cardenas, Natalia García‐Giralt, Isabelle Petit, M. Castro-Henriques Pinto-Machado et autres

es (code pays fourni par la source)

Recomendaciones sobre enfermedad tromboembólica venosa en procesos oncológicos. Una visión desde la medicina de familia

O. García Vallejo, María Dolores Aicart Bort, Miriela Fernández, J. Caballer Rodilla et autres

es (code pays fourni par la source)

242P Cyclin-dependent kinases inhibitors and dermatological reactions

L.M. Masfarre Pinto, David Pesqué, F. Amorelli, N. Navarro Gorro et autres

Cyclin 4/6 inhibitors (CDKIs) are currently used in patients with hormone-dependent breast cancer as first-line treatment for metastatic disease. One of their less frequent but equally limiting adverse events is skin toxicity. The purpose of the study was to report the incidence …

es (code pays fourni par la source)

234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study

Fernando Moreno Antón, M. Bellet-Ezquerra, L.M. Manso Sànchez, Fernando Henao et autres

PALBOSPAIN is an observational, multicenter study to evaluate real-world practice patterns and outcomes of first-line treatment for advanced breast cancer (ABC) with Palbociclib. Results from real-world progression free survival (rwPFS) and overall survival (OS) in the total population and according to endocrine …

es (code pays fourni par la source)

Concordance Between Radiological and Pathological Response in Axillary Lymph Nodes in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy

S. Servitja Tormo, L. Garrigos Cubells, A. Rodriguez Arana, M.D. Sabadell Mercadal et autres

es (code pays fourni par la source)

Accuracy of Magnetic Resonance Imaging Prediction of Pathologic Complete Response in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy

L. Garrigos Cubells, M.D. Sabadell Mercadal, A. Rodriguez Arana, J. Corominas et autres

es (code pays fourni par la source)

Appendix E. Study Details. KQ3a Harms of colonoscopy and flexible sigmoidoscopy

Evelyn P Whitlock, Jennifer Lin, Elizabeth Liles, Tracy L Beil et autres

Appendix D. Study Details KQ2B. CT Colonography, Fecal Occult Blood Tests, and Fecal DNA

Evelyn P Whitlock, Jennifer Lin, Elizabeth Liles, Tracy L Beil et autres

Appendix G. Colorectal cancer screening studies awaiting assessment

Evelyn P Whitlock, Jennifer S Lin, Elizabeth Liles, Tracy L Beil et autres

Key Questions & Results

Evelyn P Whitlock, Jennifer Lin, Elizabeth Liles, Tracy L Beil et autres